Amicus Therapeutics to Present at the Stifel 2022 Healthcare Conference

Rhea-AI Summary

Amicus Therapeutics (Nasdaq: FOLD) will participate in a fireside chat at the Stifel 2022 Healthcare Conference on November 16, 2022, at 9:45 a.m. E.T., held in New York, NY. Investors can access a live audio webcast of the presentation through the investors section of the Amicus corporate website. The company is dedicated to developing innovative medicines for rare diseases, emphasizing a strong commitment to patient care and a robust pipeline of first- or best-in-class treatments. For more details, visit the Amicus website or follow them on social media.

News Market Reaction – FOLD

+1.74%

+1.74% Session move

In the trading session that priced this news, FOLD gained 1.74%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

PHILADELPHIA, Nov. 15, 2022 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced that management will participate in a fireside chat at the Stifel 2022 Healthcare Conference in New York, NY on Wednesday, November 16, 2022 at 9:45 a.m. E.T.

A live audio webcast of the presentation can also be accessed via the investors section of the Amicus Therapeutics corporate website at https://ir.amicusrx.com/events-and-presentations.

About Amicus Therapeutics
Amicus Therapeutics (Nasdaq: FOLD) is a global, patient-dedicated biotechnology company focused on discovering, developing and delivering novel high-quality medicines for people living with rare diseases. With extraordinary patient focus, Amicus Therapeutics is committed to advancing and expanding a robust pipeline of cutting-edge, first- or best-in-class medicines for rare diseases. For more information please visit the company’s website at www.amicusrx.com, and follow on Twitter and LinkedIn.

CONTACT:

Investors:
Amicus Therapeutics
Andrew Faughnan
Executive Director, Investor Relations
afaughnan@amicusrx.com
(609) 662-3809

Media:
Amicus Therapeutics
Diana Moore
Head of Global Communications
dmoore@amicusrx.com
(609) 662-5079

FOLD–G

FAQ

When is Amicus Therapeutics participating in the Stifel 2022 Healthcare Conference?

Amicus Therapeutics will participate in the Stifel 2022 Healthcare Conference on November 16, 2022, at 9:45 a.m. E.T.

How can I access the Amicus Therapeutics presentation at the Stifel Conference?

The presentation can be accessed via a live audio webcast on the investors section of the Amicus Therapeutics corporate website.

What is the focus of Amicus Therapeutics?

Amicus Therapeutics focuses on discovering and developing novel medicines for rare diseases, with a strong commitment to patient care.

What is the stock symbol for Amicus Therapeutics?

The stock symbol for Amicus Therapeutics is FOLD.